Covered recipient · General Payments record
SUDHIR K DUTTA
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$2,934.91
- Reported across 153 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $251.65 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | $43.10 | 2 |
| PFIZER INC. | $34.43 | 2 |
| Celgene Corporation | $29.36 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $22.94 | 1 |
| Janssen Biotech, Inc. | $22.06 | 1 |
| Medtronic, Inc. | $18.05 | 1 |
| ORPHALAN INC | $17.51 | 1 |
| Ardelyx, Inc. | $16.65 | 1 |
| Sandoz Inc. | $16.20 | 1 |
| Olympus America Inc. | $15.99 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $15.36 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | $15.36 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146965692 | CMS |
| Ardelyx, Inc. | $16.65 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146678907 | CMS |
| Celgene Corporation | $14.19 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101096790 | CMS |
| Celgene Corporation | $15.17 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101096796 | CMS |
| Ipsen Biopharmaceuticals, Inc | $19.98 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091983081 | CMS |
| Ipsen Biopharmaceuticals, Inc | $23.12 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091983083 | CMS |
| Janssen Biotech, Inc. | $22.06 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078726350 | CMS |
| Medtronic, Inc. | $18.05 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117125696 | CMS |
| Olympus America Inc. | $15.99 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108479194 | CMS |
| ORPHALAN INC | $17.51 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154763769 | CMS |
| PFIZER INC. | $16.42 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131277679 | CMS |
| PFIZER INC. | $18.01 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131505899 | CMS |
| Sandoz Inc. | $16.20 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089365937 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $22.94 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137536583 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.